Table 2. Co-morbidities and electrolytes imbalance of patients with chronic heart failure (n=200) .
Co-morbidities | HFrEF (n=150) | HFpEF (n=38) | HFmrEF (n=12) |
Anemia | 112 (74.6%) | 6 (15.7%) | 2 (16.6%) |
Hypertension | 32 (21%) | 28 (73.6%) | 4 (33.3%) |
Coronary artery disease | 48 (32%) | 10(26.3%) | 2 (16.6%) |
Type 2 diabetes mellitus | 31(20.6%) | 9 (23.6%) | 0 |
Chronic kidney disease | 16 (10.6%) | 4 (10.5%) | 0 |
Hypothyroidism | 9 (6%) | 1 (2.6%) | 0 |
Chronic obstructive pulmonary disease | 10(6.6%) | - | - |
Stroke | 6 (4%) | - | - |
Hyperthyroidism | 3(2%) | - | - |
Pulmonary embolism | 3 (2%) | - | - |
Electrolytes imbalance Hyponatremia (<135 mEp/L) Hypernatremia (>145 mEq/L) Hypokalemia (< 3.5 mEq/L) Hyperkalemia (> 5 mEq/L) |
58(38.6%) 14(9.3%) 11(7.3%) 16(10.6%) |
4 (10.5%) - 4 (10.5%) 2 (5.2%) |
- - 1 (8.3%) - |
Abbreviations: HFrEF: heart failure with reduced ejection fraction; HFpEF: heart failure with preserved ejection fraction, HFmrEF: heart failure with a mid-range ejection fraction.